Clinical trial
Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil
NCT01965925 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- November 9, 2017
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.